Why the study?
Renal infarction is extremely rare and more than 95% of cases are symptomatic; no previously reported asymptomatic cases without abnormal blood and urine findings exist, and the efficacy of long-term treatment of idiopathic renal infarction remains unknown.
Case Report (n=1)
Finite anticoagulation may be feasible after asymptomatic renal infarction; leaves open prospective validation of safety and optimal duration.
Background: Renal infarction is an extremely rare disease. Although more than 95% of cases are symptomatic, there have been no previously reported asymptomatic cases, without any abnormal blood and urine test findings. Furthermore, the efficacy of long-term treatment of idiopathic renal infarction remains unknown. Case Presentation: A 63-year-old Japanese male underwent laparoscopy; a very low anterior resection of the rectum for lower rectal cancer (stage II) four years and five months prior to diagnosis with renal infarction. During the follow-up imaging studies, asymptomatic idiopathic renal infarction was found incidentally. The blood and urine test findings were normal. Contrast-enhanced computed tomography revealed a linearly bordered area of poor contrast in the dorsal region of the right kidney; however, no renal artery lesions, thromboembolic disease, or coagulation abnormalities were observed. Initial treatment with rivaroxaban 15 mg/day resulted in the remission of the infarcted lesion. The anticoagulation therapy was terminated after about 18 months without any incidences of re-infarction or bleeding events. Conclusions: We reported a very rare case of asymptomatic idiopathic renal infarction where blood and urine tests revealed no abnormal findings, and it was diagnosed incidentally during a post-treatment follow-up examination for lower rectal cancer. Long-term anticoagulant therapy for idiopathic renal infarction should be terminated at an appropriate time, taking the risk of bleeding into account.
No takes yet. Share an insight, caveat, or question.
Mizusugi et al. (2023) conducted a case report in Asymptomatic idiopathic renal infarction (n=1). Rivaroxaban was evaluated on Remission of the infarcted lesion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: